CN Patent

CN110511219B — 苯基取代的二氢萘啶类化合物及其用途

Assigned to Nianyan Pharmaceutical Zhuhai Co ltd · Expires 2022-06-03 · 4y expired

What this patent protects

本发明涉及一种苯基取代的二氢萘啶类化合物及其用途，进一步涉及包含所述化合物的药物组合物。本发明所述化合物或所述药物组合物可以用作盐皮质激素受体拮抗剂。

USPTO Abstract

本发明涉及一种苯基取代的二氢萘啶类化合物及其用途，进一步涉及包含所述化合物的药物组合物。本发明所述化合物或所述药物组合物可以用作盐皮质激素受体拮抗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN110511219B
Jurisdiction
CN
Classification
—
Expires
2022-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Nianyan Pharmaceutical Zhuhai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.